H-L-MeVal-OMe*HCl

H-L-MeVal-OMe*HCl is the hydrochloride salt of an L-configured methylated valine derivative presented as a methyl ester, featuring a chiral α-carbon, a branched isopropyl-like side chain characteristic of MeVal, and an esterified carboxyl functionality that can be converted to amide or acid forms during peptide assembly. The N-terminal portion is acetylated (H-L-MeVal-OMe*HCl is commonly handled as an amino acid methyl ester hydrochloride), providing an amine that is effectively protonated under storage conditions and can be deprotected or coupled under standard peptide chemistry. The combination of stereodefined backbone and ester activation enables controlled peptide coupling chemistry, while the hydrochloride counterion supports handling as a crystalline, salt-form intermediate. The molecule functions as a chiral amino acid ester intermediate whose functional groups participate in downstream transformations including ester hydrolysis, amidation, and incorporation into protected or activated peptide fragments.

1. Peptide Synthesis

H-L-MeVal-OMe*HCl is applied in peptide building-block preparation where an L-configured amino acid methyl ester supports stepwise peptide coupling and fragment assembly. The methyl ester at the C-terminus can be activated for amide bond formation or converted to the corresponding acid prior to coupling, while the chiral center governs stereochemical fidelity in the resulting peptide chain. The hydrochloride form helps manage the amine's protonation state during coupling workflows, enabling compatibility with common peptide coupling strategies used in research and manufacturing. Downstream, the resulting MeVal-containing peptides and peptide fragments can be used for library synthesis, scaffold optimization, and mechanistic studies in peptide chemistry.

2. Protected Amino Acid Chemistry

H-L-MeVal-OMe*HCl serves as a chiral amino acid intermediate for protected amino acid synthesis and controlled N-/C-functional group manipulation. The amino acid ester format allows selective transformations such as ester hydrolysis to generate a carboxylic acid for subsequent protection or coupling, while the stereodefined backbone supports stereospecific incorporation into larger intermediates. The hydrochloride counterion can be leveraged to manage amine reactivity during protection/deprotection sequences, aligning with protecting-group strategies typical for peptide-grade intermediates. The compound can be routed into protected derivatives that maintain the L-configuration through peptide assembly and industrial fine chemical synthesis.

3. Side-Chain Functionalization

H-L-MeVal-OMe*HCl is suitable for side-chain derivatization workflows that require a stable chiral amino acid scaffold with a branched aliphatic substituent. The MeVal side chain provides a hydrophobic handle that can be retained during functional group transformations focused on the backbone, enabling generation of analogs for structure-property and structure-activity relationship studies. The ester group enables orthogonal reactivity planning, allowing selective conversion to acids or amides while preserving side-chain integrity for subsequent conjugation or incorporation into peptidomimetic frameworks. Resulting functionalized derivatives can be used to tune physicochemical properties such as lipophilicity and conformational preferences in downstream peptide or peptidomimetic construction.

4. Chiral Synthesis Intermediate

H-L-MeVal-OMe*HCl is used as a chiral amino acid intermediate in stereoselective synthesis programs where maintaining L-stereochemistry is essential. The defined α-amino acid stereocenter and ester functionality support its role as a downstream precursor for chiral building blocks, including activated acids, amide-forming derivatives, and peptide coupling partners. The hydrochloride salt form supports reproducible handling and can facilitate consistent conversion to reactive forms during process chemistry intermediate preparation. The compound's structure aligns with chiral manufacturing routes that require stereochemical control from amino acid ester to peptide-grade intermediates.

5. Pharmaceutical Manufacturing Intermediates

H-L-MeVal-OMe*HCl can be incorporated into industrial intermediate supply chains for manufacturing of amino acid-derived fragments used in peptide-based or peptidomimetic manufacturing workflows. The amino acid ester and protonated amine functionality support conversion into coupling-ready forms that feed into larger synthetic sequences for drug-like scaffolds and research-grade reference materials. The stereodefined L-configuration reduces the need for downstream stereochemical correction steps when MeVal residues must be introduced with defined stereochemistry. Industrial utilization commonly focuses on producing consistent chiral intermediates that integrate into controlled peptide coupling and subsequent purification steps in fine chemical and pharmaceutical intermediate production.

1. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum

2. Zeta-potential-changing nanoparticles conjugated with cell-penetrating peptides for enhanced transfection efficiency

3. Exosomes-mediated Transfer of miR-125a/b in Cell-to-cell Communication: A Novel Mechanism of Genetic Exchange in the Intestinal Microenvironment

4. A possible role of tachykinin-related peptide on an immune system activity of mealworm beetle, Tenebrio molitor L

5. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy